BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11159537)

  • 21. Stat3-dependent induction of BATF in M1 mouse myeloid leukemia cells.
    Senga T; Iwamoto T; Humphrey SE; Yokota T; Taparowsky EJ; Hamaguchi M
    Oncogene; 2002 Nov; 21(53):8186-91. PubMed ID: 12444555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placental Growth Factor and Vascular Endothelial Growth Factor Together Regulate Tumour Progression via Increased Vasculature in Cutaneous T-cell Lymphoma.
    Miyagaki T; Sugaya M; Oka T; Takahashi N; Kawaguchi M; Suga H; Fujita H; Yoshizaki A; Asano Y; Sato S
    Acta Derm Venereol; 2017 May; 97(5):586-592. PubMed ID: 28119994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells.
    Nielsen M; Kaestel CG; Eriksen KW; Woetmann A; Stokkedal T; Kaltoft K; Geisler C; Röpke C; Odum N
    Leukemia; 1999 May; 13(5):735-8. PubMed ID: 10374878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional control of impaired Th1 responses in patent lymphatic filariasis by T-box expressed in T cells and suppressor of cytokine signaling genes.
    Babu S; Kumaraswami V; Nutman TB
    Infect Immun; 2005 Jun; 73(6):3394-401. PubMed ID: 15908366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma.
    Mehdi SJ; Moerman-Herzog A; Wong HK
    BMC Cancer; 2021 May; 21(1):492. PubMed ID: 33941102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.
    Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B
    J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling.
    Tanuma N; Shima H; Nakamura K; Kikuchi K
    Blood; 2001 Nov; 98(10):3030-4. PubMed ID: 11698287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
    Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
    Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma.
    Wong HK
    Discov Med; 2013 Sep; 16(87):71-8. PubMed ID: 23998443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma.
    Sakamoto M; Miyagaki T; Kamijo H; Oka T; Boki H; Takahashi-Shishido N; Suga H; Sugaya M; Sato S
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia.
    Faderl S; Harris D; Van Q; Kantarjian HM; Talpaz M; Estrov Z
    Blood; 2003 Jul; 102(2):630-7. PubMed ID: 12663443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stat1-independent induction of SOCS-3 by interferon-gamma is mediated by sustained activation of Stat3 in mouse embryonic fibroblasts.
    Ramana CV; Kumar A; Enelow R
    Biochem Biophys Res Commun; 2005 Feb; 327(3):727-33. PubMed ID: 15649407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3.
    Huang A; Zhang YY; Chen K; Hatakeyama K; Keaney JF
    Circ Res; 2005 Feb; 96(2):164-71. PubMed ID: 15604419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6.
    Schuringa JJ; Wierenga AT; Kruijer W; Vellenga E
    Blood; 2000 Jun; 95(12):3765-70. PubMed ID: 10845908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity.
    Karlsen AE; Rønn SG; Lindberg K; Johannesen J; Galsgaard ED; Pociot F; Nielsen JH; Mandrup-Poulsen T; Nerup J; Billestrup N
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12191-6. PubMed ID: 11593036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of SOCS genes in normal and leukemic human leukocytes stimulated by prolactin, growth hormone and cytokines.
    Dogusan Z; Hooghe-Peters EL; Berus D; Velkeniers B; Hooghe R
    J Neuroimmunol; 2000 Sep; 109(1):34-9. PubMed ID: 10969179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3.
    Denson LA; Held MA; Menon RK; Frank SJ; Parlow AF; Arnold DL
    Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G646-54. PubMed ID: 12519742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
    Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
    Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.